| Vitamin D in chronic kidney disease: new potential for intervention. | |
| | |
MedLine Citation:
|
PMID: 20795938 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Prevention of progressive renal function loss and its complications remains the main challenge in clinical nephrology. Although current therapeutic strategies aiming at reduction of blood pressure and proteinuria often slow down deterioration of renal function, still many patients progress to end-stage renal disease. The development of novel pharmacological approaches for treatment of chronic kidney disease (CKD) is therefore instrumental. Here we review the renoprotective potential of vitamin D and its analogues. In CKD patients, vitamin D deficiency is common and progression of CKD is associated with low (active) vitamin D levels. Moreover, in animal models of CKD, treatment with vitamin D (analogues) alone or in combination with renin-angiotensin-aldosterone system (RAAS) blockade reduces proteinuria, glomerulosclerosis and tubulointerstitial fibrosis. Potential underlying mechanisms include suppression of the RAAS, modulation of immune cell function and direct protective effects on renal cells such as podocytes. Whether vitamin D analogues could further optimize existing therapies in human renal disease is currently under investigation. |
| | |
Authors:
|
Katarina Mirković; Jaap van den Born; Gerjan Navis; Martin H de Borst |
Related Documents
:
|
1098648 - Glomerulopathies in human renal allografts. 1465088 - Aminopeptidase a (= angiotensinase a) in human progressive renal disease. 8078178 - Pattern of renal disease in children. 20056758 - Assessment of renal pathology and dysfunction in children with fabry disease. 6733988 - Hemoperitoneum during continuous ambulatory peritoneal dialysis: a possible complicatio... 8815558 - Mp 48 expression in red blood cells of renal transplant recipients. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Current drug targets Volume: 12 ISSN: 1873-5592 ISO Abbreviation: Curr Drug Targets Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-05 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960531 Medline TA: Curr Drug Targets Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 42-53 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, University Medical Center Groningen, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vitamin D in atherosclerosis, vascular disease, and endothelial function.
Next Document: Vitamin D biology in heart failure: molecular mechanisms and systematic review.